TPWA
GMAB icon

Twin Peaks Wealth Advisors’s Genmab GMAB Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-249
Closed -$6.68K – 1023
2026
Q1 		$6.68K Buy
+249
New +$7.46K ﹤0.01% 1265
2025
Q3 		– Sell
-187
Closed -$4.09K – 948
2025
Q2 		$4.09K Buy
+187
New +$3.84K ﹤0.01% 1390

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Twin Peaks Wealth Advisors's GMAB Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Genmab (GMAB) in Q2 2026, closing a stake of 249 shares — an estimated $6.68K sold.

Twin Peaks Wealth Advisors first reported a position in GMAB in Q2 2025 and held it in 2 quarters. The position peaked at $6.68K in Q1 2026. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Genmab position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 249 Genmab shares in Q2 2026, an estimated $6.68K.
  • Twin Peaks Wealth Advisors first reported a position in Genmab in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Genmab position peaked at $6.68K in Q1 2026.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.